Table 8 25 % varying impact on TDF outcomes
|  | Age | HBeAg (−) rate (%) | TDF: virologic response 48th week in HBeAg (−) (%) | TDF: virologic response 48th week in HBeAg (+) (%) | TDF annual drug cost (TL) |
|---|---|---|---|---|---|
Base case | 40 | 70 | 93.2 | 76.1 | 2236 |
25Â % increase | 50 | 88 | 100.0 | 95.2 | 2796 |
25Â % decrease | 30 | 53 | 69.9 | 57.1 | 1677 |